Digestive Care Inc

Home Page

Products

Pertzye® Patient Programs

Educational Materials

Company Contact

Steve Berens
Vice President, Sales and Marketing
email: steveberens@pertzye.com

Digestive Care, Inc.
1120 Win Drive
Bethlehem, PA 18017
Phone: 1-877-882-5950
email: questions@pertzye.com

Digestive Care News Releases

Digestive Care, Inc. Announces FDA Approval of a 24,000 USP Lipase Units Capsule of PERTZYE® (pancrelipase) Delayed Release Capsules to Treat Exocrine Pancreatic Insufficiency (EPI) Due to Cystic Fibrosis and Other Conditions

07/14/2017

Digestive Care, Inc. Announces FDA Labeling Revision Approval for PERTZYE® (pancrelipase) Administering PERTZYE® through a gastrostomy tube

07/12/2017

Digestive Care, Inc. Announces FDA Approval of Infant–Specific Dose of PERTZYE® (pancrelipase) Delayed-Release Capsules to Treat Exocrine Pancreatic Insufficiency (EPI) Due to Cystic Fibrosis

10/10/2016

Digestive Care, Inc. Donates Year-Long Supply of PERTZYE® (pancrelipase) to Cystic Fibrosis Patients in El Salvador

03/23/2014

Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE® (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis

05/09/2013

Digestive Care, Inc. Launches a Co-Pay Assistance Program in Cooperation with CF Services Pharmacy.

12/10/2012

Digestive Care Inc. Announces FDA Approval of PERTZYE ® (pancrelipase) Delayed-Release Capsules.

5/18/2012